Endocrine
Genetic testing for medullary thyroid cancer
What is RET proto-oncogene?
Episodic hemolysis, marrow aplasia, unusual site of thrombosis, erythrocytes lacking CD55 and CD59
Paroxysmal nocturnal hemoglobinuria (PNH)
Trigeminal neuralgia treatment
Carbamazepine
Disease that includes Rheumatoid Arthritis, neutropenia, splenomegaly
Felty Syndrome
CD4 count associated with increased risk for toxoplasmosis
<100/µL
Drug class used before adrenalectomy for pheochromocytoma
α-Receptor blocker
Preferred therapy for acute chest syndrome and/or ARDS in Sickle cell disease.
Exchange transfusion
Drug treatment of subarachnoid hemorrhage
Nimodipine
First-line treatment of ankylosing spondylitis
NSAID
Most common cause of small-bowel bleeding
Angiodysplasia
Nonpituitary endocrine cause of hyperprolactinemia
Hypothyroidism
Condition characterized by Nephrotic syndrome, cardiomegaly, macroglossia
Amyloidosis
Neurologic complication of natalizumab therapy
Progressive Multifocal leukoencephalopathy (PML)
Disease characterized by Interstitial lung disease, Raynaud phenomenon, inflammatory arthritis, mechanic's hands
Antisynthetase syndrome
Treatment of H pylori-associated gastric MALT
PPI plus antibiotics
Most common cause of acquired hypocalcemia
CKD
Bisphosphonate that improves survival in MM
Zoledronic acid
Initial treatment for confirmed intracranial hypotension
Epidural blood patch
Treatment of scleroderma renal crisis
Best answer: Captopril.
Also accept ACEi
Diagnosis for normal anion gap metabolic acidosis with positive urine anion gap
Distal RTA
Screening test for mild autonomous cortisol excess in adrenal incidentaloma
1-mg overnight dexamethasone suppression test
Management of porphyria cutanea tarda
Phlebotomy and/or low-dose hydroxychloroquine (accept either)
Medications that may exacerbate myasthenia gravis (need 2 answers)
Aminoglycosides, fluoroquinolones, magnesium, β-blockers, hydroxychloroquine
Treatment of primary CNS angiitis
Cyclophosphamide with high-dose glucocorticoids
Antibody associated with primary membranous nephropathy
Anti-PLA2R